✦ LIBER ✦
PCN91 BEVACIZUMAB + PACLITAXEL + CARBOPLATIN (BEV + PAC + CAR) VS. PEMETREXED + CISPLATIN (PEM + CIS) IN ADENOCARCINOMA NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A COST-EFFECTIVENESS ANALYSIS FROM A POLISH PUBLIC PAYER'S PERSPECTIVE
✍ Scribed by P Kawalec; P Badurak; T Denisso; D Jastrzebski; M Marek; A Pluzanski; A Szczesna; M Szkultecka-Debek; M Russel-Szymczyk
- Book ID
- 118614181
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 77 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.